Wave Life Sciences logo
WVEWave Life Sciences
Trade WVE now
Wave Life Sciences primary media

About Wave Life Sciences

Wave Life Sciences (NASDAQ:WVE) is a biotechnology company focused on advancing the field of genetic medicines. Its operations revolve around developing innovative therapies using its proprietary chemistry platform, aimed at addressing unmet medical needs in various diseases. The company's projects include research and development in areas such as neuromuscular diseases, central nervous system disorders, and genetic skin diseases, with the objective of creating a pipeline of transformative drugs. Through collaboration and rigorous science, Wave Life Sciences aims to deliver life-changing treatments to patients worldwide. Wave Life Sciences is currently traded exclusively on the NASDAQ under the symbol WVE.

What is WVE known for?

Snapshot

Public US
Ownership
2012
Year founded
313
Employees
Cambridge, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Wave Life Sciences

  • Development of innovative genetic medicines using proprietary stereopure oligonucleotide technology.
  • Pipeline focused on treatments for genetic neurological disorders and liver diseases.
  • Collaboration on exon skipping programs for Duchenne muscular dystrophy treatments.
  • Research in therapies targeting central nervous system disorders including Alzheimer's and Huntington's diseases.
  • Advancement of nucleic acid therapeutic candidates for genetically defined diseases.
  • Partnership initiatives to leverage platform technology in developing precision medicine solutions.

Wave Life Sciences executive team

  • Dr. Paul B. Bolno M.B.A., M.D.President, CEO & Director
  • Dr. Gregory L. Verdine Ph.D.Founder & Director
  • Mr. Kyle B. Moran CFACFO & Principal Accounting Officer
  • Dr. Chandra Vargeese Ph.D.Chief Technology Officer
  • Dr. Christopher Francis Ph.D.Senior VP of Corporate Development & Head of Emerging Areas
  • Dr. Erik Ingelsson M.D., Ph.D.Chief Scientific Officer
  • Ms. Kate RauschHead of Investor Relations
  • Ms. Linda Rockett J.D.Senior VP & General Counsel
  • Ms. Daryn LewisSenior VP & Head of Human Resources
  • Dr. Sridhar Vaddeboina M.B.A., Ph.D.Senior Vice President of Chemistry, Manufacturing & Controls

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.